12E7 antibody that can be used to diagnose and differentiation of peripheral ectodermal tumors (PNET) and Ewing's sarcomas, as well as in therapeutic applications and bone marrow transplantation.
Lab Designation: RB6 8C5; A rat-mouse hybridoma cell line producing a monoclonal IgG2b rat AB which recognizes most, if not all, granuloytes and granolucyte precursors in the mouse bone marrow.
Lab designation: RA3 6B2; A rat-mouse hybridoma cell line producing a monoclonal IgG2a rat AB which recognizes a B cell specific form of the T200 family of cell surface glycoproteins. B220 was first characterized by another MAB, RA3-3A1.
The 4G7 hybridoma secretes an IgG1 antibody that is specific for normal and malignant B lymphocytes and can be used for the study of B cell differentiation and for the characterization of lymphoid malignancies.
This antibody(MEL-14) is specific for a single class of lymphocyte surface molecules that appear to mediate recognition of lymph node high endothelial venules and that appear to be required for lymphocyte homing to lymph nodes in vivo.
Anti-mouse endoglin MAb MJ7/18.
A rat IgG2A MAb recognizing mouse endoglin. In the mouse, endoglin serves as a specific endothelial cell differentiation antigen. Endoglin has been implicated as TGFb3-binding molecule.
293T is a human cell line that has unique properties useful in many applications, including those requiring efficient transfection, gene expression, DNA replication, or viral production.
Rapid, Stable, High titre production of Recombinant Retrovirus
This method of rapid production of high titre retrovirus for large scale production involves a retrovirus construct with an Epstein Barr Virus origin of replication and EBNA protein.
This invention consists of mouse L1/2 pre B cells and human Jurkat cells transfected with serpentine receptors. These cell lines have been shown to be induced by specific ligands to activate lymphoid cell integrins and hence cell adhesion.
Alloreaction-associated antigen (ARAg) is a novel member of the immunoglobulin superfamily. This invention's issued US patent claims composition of matter of ARAg polypeptides and nucleic acids encoding ARAg polypeptides.